Rohto Pharmaceutical Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Rohto Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥2,965. The average 1-year stock price forecast is 29.57% higher than the current stock price, while the lowest is ¥2,300 (+0.52%) and the highest is ¥3,400 (+48.60%).

Price Target: ¥2,965 (+29.57%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	¥2,300	¥2,965	¥2,980	¥3,400
Change	+0.52%	+29.57%	+30.24%	+48.60%

* Price targets were last updated on Dec 24, 2025.

Analyst Ratings

The average analyst rating for Rohto Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	3	4	4	4
Buy	3	3	3	3	3	4
Hold	4	4	4	4	4	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Hisae Kawamoto Jefferies	Jefferies	Buy Upgrades ¥2,980	Buy	Upgrades	¥2,980	+30.24%	Dec 24, 2025
Unknown Analyst UBS No rating	UBS	Hold Initiates ¥2,600	Hold	Initiates	¥2,600	+13.64%	Dec 12, 2025

Financial Forecast

Revenue This Year

366.65B

from 343.73B

6.67%

from 343.73B

Revenue Next Year

382.53B

from 366.65B

4.33%

from 366.65B

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	199.65B	238.66B	270.84B	308.63B	343.73B	366.65B
Revenue Growth	10.13%	19.54%	13.48%	13.95%	11.37%	6.67%
Gross Profit	116.49B	137.42B	157.29B	174.94B	192.70B	212.20B
Gross Margin	58.35%	57.58%	58.07%	56.68%	56.06%	57.88%
Operating Income	28.19B	33.54B	40.17B	38.47B	40.71B	44.63B
Net Income	21.02B	26.38B	30.94B	31.01B	34.25B	35.09B
Dividend / Share	18.00	22.00	27.00	36.00	46.00	49.36
Dividend Growth	-	22.22%	22.73%	33.33%	27.78%	7.29%
Free Cash Flow	11.70B	12.45B	15.30B	16.65B	9.06B	26.25B
No. Analysts	-	-	-	-	-	10

Financial currency is JPY.

Revenue Forecast

Revenue	2027	2028	2029
High	376.8B
Avg	366.7B
Low	353.5B

Revenue Growth

Revenue Growth	2027	2028	2029
High	9.6%
Avg	6.7%
Low	2.8%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2028	2029
High	-
Avg	-
Low	-